| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972430 | The Journal of Heart and Lung Transplantation | 2008 | 10 Pages |
Abstract
Our data demonstrate that supCD28 MAb targets expansion of nTreg cells in vivo and maintains and enhances their regulatory functions, which represents a major advance toward the therapeutic use of polyclonally activated Treg cells as cellular therapy for treatment of allograft rejection.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yusuke PhD, Masayuki PhD, Takatoshi BS, Haruhito MD, PhD, Hiromitsu MD, Yoshitaka MD, PhD, Shiro MD, PhD, Thomas MD, PhD, Ryo MD, PhD, Xiao-Kang MD, PhD,